
A study conducted by researchers at UT Southwestern’s Simmons Cancer Center has revealed that a combination of two specific drug …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

